Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The ETO (MTG8) gene family.

Davis JN, McGhee L, Meyers S.

Gene. 2003 Jan 16;303:1-10. Review.

PMID:
12559562
2.

AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.

Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD.

Blood. 2000 Dec 1;96(12):3939-47.

3.

Multiple regions of ETO cooperate in transcriptional repression.

Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB.

J Biol Chem. 2001 Mar 30;276(13):9889-95. Epub 2001 Jan 9.

4.

Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins.

Heibert SW, Lutterbach B, Durst K, Wang L, Linggi B, Wu S, Wood L, Amann J, King D, Hou Y.

Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S31-4. Review.

PMID:
11587363
5.

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.

Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10860-5.

6.

ETO interacting proteins.

Hug BA, Lazar MA.

Oncogene. 2004 May 24;23(24):4270-4. Review.

PMID:
15156183
7.

Molecular basis of the t(8;21) translocation in acute myeloid leukaemia.

Ohki M.

Semin Cancer Biol. 1993 Dec;4(6):369-75. Review.

PMID:
8142622
8.

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.

Licht JD.

Oncogene. 2001 Sep 10;20(40):5660-79. Review. No abstract available.

9.

The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.

Lausen J, Cho S, Liu S, Werner MH.

J Biol Chem. 2004 Nov 19;279(47):49281-8. Epub 2004 Sep 17.

10.

Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism.

McGhee L, Bryan J, Elliott L, Grimes HL, Kazanjian A, Davis JN, Meyers S.

J Cell Biochem. 2003 Aug 1;89(5):1005-18.

PMID:
12874834
11.

Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8).

Odaka Y, Mally A, Elliott LT, Meyers S.

Oncogene. 2000 Jul 27;19(32):3584-97.

12.

ETO-2, a new member of the ETO-family of nuclear proteins.

Davis JN, Williams BJ, Herron JT, Galiano FJ, Meyers S.

Oncogene. 1999 Feb 11;18(6):1375-83.

13.

Domains involved in ETO and human N-CoR interaction and ETO transcription repression.

Wang J, Wang M, Liu JM.

Leuk Res. 2004 Apr;28(4):409-14.

PMID:
15109542
14.

The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1.

Kitabayashi I, Ida K, Morohoshi F, Yokoyama A, Mitsuhashi N, Shimizu K, Nomura N, Hayashi Y, Ohki M.

Mol Cell Biol. 1998 Feb;18(2):846-58.

15.

Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.

Fliegauf M, Stock M, Berg T, Lübbert M.

Oncogene. 2004 Dec 2;23(56):9070-81.

PMID:
15489901
16.

Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.

Kasashima K, Sakota E, Kozu T.

Biochimie. 2004 Sep-Oct;86(9-10):713-21.

PMID:
15556282
17.

Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.

Barseguian K, Lutterbach B, Hiebert SW, Nickerson J, Lian JB, Stein JL, van Wijnen AJ, Stein GS.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15434-9. Epub 2002 Nov 11.

18.

The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor.

McNeil S, Zeng C, Harrington KS, Hiebert S, Lian JB, Stein JL, van Wijnen AJ, Stein GS.

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14882-7.

19.

The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.

Elsässer A, Franzen M, Kohlmann A, Weisser M, Schnittger S, Schoch C, Reddy VA, Burel S, Zhang DE, Ueffing M, Tenen DG, Hiddemann W, Behre G.

Oncogene. 2003 Aug 28;22(36):5646-57.

PMID:
12944913
20.

MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).

Kozu T, Fukuyama T, Yamami T, Akagi K, Kaneko Y.

Genes Chromosomes Cancer. 2005 May;43(1):45-53.

PMID:
15723339

Supplemental Content

Support Center